|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||97.10 - 101.50|
|52 Week Range||97.10 - 134.29|
|PE Ratio (TTM)||15.69|
|Earnings Date||Jul 24, 2018|
|Forward Dividend & Yield||4.00 (4.06%)|
|1y Target Est||121.21|
Kimberly-Clark (KMB) reported an improved sales and earnings performance in 1Q18. The company surpassed analysts’ expectations both on the sales and EPS fronts. However, continued pressure on margins, promotional spending to drive volumes, and lower pricing remained a drag and continued to hurt its margins. The company’s gross margin fell significantly in 1Q18, which prompted a couple of analysts to lower the target price on Kimberly-Clark stock. Jefferies lowered its price target to $102 per share from $110. Meanwhile, Wells Fargo reduced its target price on KMB stock to $92 from $100.
The home and personal care product manufacturers in the US continue to disappoint with their margin performance. Significant inflation in commodities, promotional spending to drive volumes, lower net price realization, and a tough retail environment are taking a toll on the profit margins of the companies operating in this space.
Kimberly-Clark’s (KMB) Personal Care segment reported sales of $2.3 billion, up 2.5% on a YoY (year-over-year) basis. Favorable currency rates and benefits from the acquisition of its joint venture in India helped drive the segment’s sales higher.
Kimberly-Clark (KMB) sustained its sales momentum in 1Q18. The company’s net sales of $4.7 billion exceeded analysts’ expectations and increased 5.1% on a YoY (year-over-year) basis thanks to the favorable currency rates, which contributed about 3.0% to the top-line growth rate. Plus, investments in brands to support volumes dented the net sales growth rate.
Kimberly-Clark (KMB) reported stronger-than-expected 1Q18 earnings. Kimberly-Clark’s adjusted earnings of $1.71 per share came in ahead of the consensus estimate of $1.69 and rose 8.9% on a YoY (year-over-year) basis. The company has now surpassed analysts’ expectations in three quarters despite pressure on margins from significant inflation in input costs and lower net price realization.
Like Procter, on the surface, you could make a strong case to own Kimberly-Clark given its release where the company talked about 2% growth and some very strong numbers in consumer tissue -- think Kleenex -- and personal care. Tissue sales in North America increased 6% and developing and emerging markets increased 7%. Kimberly's professional segment increased 5%.
Most analysts covering Church & Dwight (CHD) stock have recommended “hold,” despite the company’s strong sales and earnings performance in the past two quarters and upbeat guidance. Church & Dwight’s sales and adjusted earnings grew by double digits during the last reported quarter, and they are expected to sustain that momentum in 1Q18.
Analysts expect Church & Dwight (CHD) to report strong sales and earnings growth in the upcoming quarter. Church & Dwight is expected to announce its 1Q18 results on May 3, 2018, and analysts expect the company’s top line to rise 11.5% YoY (year-over-year), more than peers’.
Kimberly-Clark's (KMB) first-quarter 2018 results gain from top-line growth across all segments. The company's savings initiative bore positive results.
Church & Dwight (CHD) stock fell ~6% on Friday, April 20, 2018, after being downgraded by Deutsche Bank to “hold” from “buy.” Its price target was lowered to $50 per share from $56. Investors are skeptical on the prospects of household and personal care product manufacturers, which are facing increased price competition, a challenging retail scenario, and margin headwinds.
was reviewed in February, where I noted that, "In this Point and Figure chart of KMB a downside price target of $99.06 is shown but a trade down to $108.68 would be needed to weaken prices." Looking back at the price action since February we can see that prices began to accelerate to the downside in late March breaking below $108.68 and reaching the $99.06 price target. In this daily bar chart of KMB, below, we can see a downtrend in place for the past twelve months. The daily On-Balance-Volume (OBV) line moved lower from July to November telling us that sellers of KMB were more aggressive.
Kimberly-Clark (KMB) expects adjusted earnings for 2018 in a range of $6.90-$7.20 per share, reflecting year-over-year growth of 11-16%.
The toymaker reported adjusted quarterly profit of 10 cents per share , compared to a consensus forecast of 33 cents a share. Revenue was also well below forecasts, with Hasbro citing the liquidation of Toys 'R' Us as a significant negative event for its results. Henry Schein HSIC – The provider of products and services to health-care offices will spin off its animal health business and merge it with that of Vets First Choice, a provider of services to veterinary practices.
(Reuters) - Huggies and Kleenex producer Kimberly-Clark Corp (KMB.N) reported better-than-expected first-quarter profit and sales on Monday, helped by strong growth in tissue sales. Shares of the company ...
Huggies and Kleenex producer Kimberly-Clark Corp reported better-than-expected first-quarter profit and sales on Monday, helped by strong growth in tissue sales. Shares of the company rose 2.5 percent ...
The Dallas-based company said it had profit of 26 cents per share. Earnings, adjusted for restructuring costs and pretax expenses, came to $1.71 per share. The results matched Wall Street expectations. ...
Kimberly-Clark Corp, the maker of Huggies diapers and Kleenex tissues, reported better-than-expected first-quarter sales, helped by its personal care business. Net income attributable to shareholders fell ...
DALLAS , April 23, 2018 /PRNewswire/ -- Kimberly-Clark Corporation (NYSE: KMB) today reported first quarter 2018 results. Executive Summary First quarter 2018 net sales of $4.7 billion increased 5 percent ...
Kimberly-Clark shares rose in pre-market trade after the company boosted its sales forecasts for 2018 following encouraging growth in its personal care and tissue products during the first quarter. However, ...
Procter and Gamble (PG) saw improved sales and earnings performance in fiscal 3Q18. The company’s top and bottom line surpassed analysts’ expectations. However, the company’s soft organic sales growth rate and sluggish margins due to lower pricing and increased costs didn’t sit well with analysts.
Procter & Gamble (PG) continued to report sluggish margins in fiscal 3Q18. The company’s core gross margin fell 110 basis points to 49.4% in fiscal 3Q18 as lower pricing to drive volumes and increased cost pressure more than offset the benefits stemming from cost and productivity savings.
Lower pricing adversely impacted Procter & Gamble’s (PG) sales across product segments amid increased competitive activity. However, favorable currency rates and improved volumes drove top-line growth.